NLS Pharmaceutics AG
Records under this name other than the patents NLS Pharmaceutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to NLS Pharmaceutics AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,637,447 | Lauflumide and the Enantiomers Thereof, Method for Preparing Same and Therapeutic Uses Thereof Lapsed on the fee record Ended May 2, 2025 · High confidence | Lapsed on the fee record | Ended May 2, 2025 | High confidence |
| US 10,532,100 | Use of iron for treating attention deficit hyperactivity disorder in children Lapsed on the fee record Ended Jan 14, 2024 · High confidence | Lapsed on the fee record | Ended Jan 14, 2024 | High confidence |
| US 10,456,387 | Phacetoperane for treating of attention deficit hyperactivity disorder Lapsed on the fee record Ended Oct 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2023 | From the USPTO record |